SEC Form 4 · accession 0001209191-15-024551
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole R. Hadas
Officer — SVP, General Counsel, Sec.
Period of report
Mar 6, 2015
Accepted (ET)
Mar 10, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.15 | Mar 6, 2015 | A | 30,000 | A | — | Mar 6, 2025 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F125% of this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.